Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) — Capital Reinvestment Ratio

Latest as of June 2025: 209.97x

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a Capital Reinvestment Ratio of 209.97x as of June 2025, meaning it reinvests 210% of its operating cash flow (TL637.87K) in capital expenditures (TL133.93 Million). Check ANGEN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

209.97x
Capex / Operating Cash Flow

Operating Cash Flow

TL637.87K
TRY

Capital Expenditures

TL133.93 Million
TRY

Data as of

Jun 2025
Most recent filing

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Capital Reinvestment Ratio (2020–2024)

This chart tracks Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Anatolia Tani ve Biyoteknoloji Urunleri cash conversion from operations.

Annual Capital Reinvestment Ratio for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2020–2024)

Year-by-year Capital Reinvestment Ratio for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2020 to 2024. See ANGEN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (TRY) Capital Expenditures YoY Change
2024 1.74x TL141.41 Million TL246.49 Million ▲ +342.8%
2023 0.39x TL424.36 Million TL167.05 Million ▲ +30.1%
2022 0.30x TL311.02 Million TL94.11 Million ▲ +59.1%
2021 0.19x TL407.20 Million TL77.43 Million ▼ -35.7%
2020 0.30x TL235.47 Million TL69.59 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow